KDDI starts commercial deployment of 5G Open vRAN sites in Japan in collaboration with Samsung Electronics and Fujitsu Limited JCN Newswire

KDDI starts commercial deployment of 5G Open vRAN sites in Japan in collaboration with Samsung Electronics and Fujitsu Limited

January 24, 2023
TOKYO, Jan 24, 2023 - (JCN Newswire via SEAPRWire.com) - KDDI CORPORATION announced that, in cooperation with Samsung Electronics Co., Ltd. and Fujitsu Limited, it initiated the commercial deployment of O-RAN(1) compliant 5G Open Virtual Radio Access Network (hereinafter Open vRAN) sites in Osaka City, Osaka Prefecture, Japan, on January 19, 2023.The expansion of 5G services promises a variety of exciting new applications that offer the possibility of a more connected world, realized through unprecedented speeds achieved with leading edge communication technologies. The sudden increase of different network-connected devices is also expected to lead to a rapid increase in communication volume, however, creating strain for communications networks. Building advanced systems that can handle this increase in traffic, as well as achieving faster deployment and lower costs for network technologies represent an urgent priority for vendors working to build 5G network infrastructure. To meet these growing demands, KDDI has been developing O-RAN compliant 5G Open vRAN sites using Samsung's virtualized solutions. By offering an open, wireless system, KDDI aims to contribute to the expansion of equipment procurement options and the construction of high-performance, cost-effective infrastructure.For the new sites, KDDI updated the software of an O-RAN compliant 5G Open vRAN site(2) KDDI successfully turned on in February 2022. Samsung's 5G virtualized CU (vCU) and virtualized DU (vDU) and Fujitsu's radio units (MMU: Massive MIMO Units) are interconnected with an open interface. Wireless controllers are equipped with fully-virtualized RAN software on general-purpose servers to realize network functions, while wireless devices are both compact and lightweight and consume less power by utilizing high-efficiency, wide-band power amplification technology. Core functions are implemented as software to enable flexible and efficient management of network resources. KDDI further updated the software of the new sites to support the 5G NSA solution connected to existing 4G sites and functions that were realized in conventional sites using dedicated equipment including Multi-User MIMO (MU-MIMO)(3). As a result, customers with existing 5G NSA smartphones will be able to enjoy the same comfortable communication as before. Moreover, this is the world's first commercial MU-MIMO implementation with O-RAN compliant multivendor interoperability(4).In addition, KDDI constructed a Zero Touch Provisioning system to automate configuration tasks when the base stations start operating. The system automates the setup of servers and virtualized platforms from different vendors and contributes to rapid base station deployment nationwide, including in rural areas. Based on the knowledge gained from its operation in Osaka City, the parties aim to expand the scope of application of this system in 2024 to realize full-scale deployment of Open vRAN sites to provide customers with an even faster and more comfortable communication environment.Moving forward, KDDI, Samsung and Fujitsu will continue to develop solutions for Open vRAN in Japan and promote nationwide deployment of 5G SA(5) services for KDDI to provide customers with new experiences and contribute to business development.(1) O-RAN ALLIANCE designated specifications for RAN interfaces that support interoperation between various vendors' equipment(2) "KDDI Successfully Turns on the World's First 5G Standalone Open RAN Site Powered by vRAN in Japan - Using Open RAN architecture powered by vRAN, KDDI accelerates the delivery of enhanced mobile services to its customers" (press release, February 18, 2022)(3) A technology in which a radio site estimates the propagation path state with high accuracy and simultaneously communicates with a plurality of terminals using beamforming technology.(4) Based on Samsung's market research as of Jan. 24, 2023.(5) A system that combines 5G sites with core network equipment developed exclusively for 5G.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com. Copyright 2023 JCN Newswire. All rights reserved. (via SEAPRWire)
More
Novotech is Gold Sponsor at Biotech Showcase 2023 ACN Newswire

Novotech is Gold Sponsor at Biotech Showcase 2023

December 20, 2022
SYDNEY, AU, Dec 20, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO Dr. John Moller and experts from the Novotech US and Asia Pacific teams will be attending the conference.Meetings can be scheduled via the PartneringOne portal. https://informaconnect.com/biotech-showcase/partnering/Novotech will share the Asia Pacific advantages for expedited clinical trials, where biotechs have access to Novotech's vast patient populations, strong local regulatory knowledge, extensive site and KOL networks, and reputation for data quality.Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions in Asia Pacific delivering exclusive benefits for sponsors.The latest industry research publication by GlobalData and Novotech found almost 50% of new trials globally have sites in Asia Pacific. According to the new publication titled "State of the Global Biotech Landscape: Where the Opportunities Lie", demand for Asia Pacific trial sites is strong with almost half of the more than 27,000 clinical trials initiated in 2021 having sites in Asia Pacific. The data shows almost 12,900 of the new trials had sites in Asia Pacific.Download the report here https://novotech-cro.com/whitepapers/state-global-biotech-landscape-where-opportunities-lieThe report also noted that the Asia Pacific region, which has more than 6,772 trial sites each with access to an average of 2,136 million people, has considerable underutilized capacity presenting an opportunity for growth in multinational trials in the region. Novotech this month was awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in the Asia-Pacific contract research organization industry. Novotech has been a recipient of the Frost & Sullivan Asia Pacific Best Practices awards since 2006.Frost & Sullivan said: "Our approach involves the deployment of best practices and strategic analytics across a value chain. Against this backdrop, Frost & Sullivan recognizes Novotech for its valuable achievement. Novotech addresses the global drug development market's unmet needs with a strong leadership focus that incorporates client-centric strategies with best-practice implementation. From feasibility assessments to regulatory submission support, data management, medical monitoring, and project management, the company provides a 360-degree approach to drug development for its biotech clients."Novotech also recently produced a new publication for biotechs considering China for their clinical research, and the relevant processes required for global regulatory approvals. The report details regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful US FDA approval pathway. Novotech provides the relevant regulatory knowledge and drug development pathways specifically designed to support the US FDA approval process, avoiding delays and additional costs.Download whitepaper here https://novotech-cro.com/whitepapers/china-biotech-landscape-opportunities-china-and-path-usfda-approvalNovotech has also recently been benchmarked as a top 10 CRO among the world's leading CROs, is a finalist in the prestigious Scrip awards, and has just been awarded the Gene & Cell Therapy Excellence Award. About Novotech - https://novotech-cro.comNovotech is internationally recognized as the leading Asia Pacific centred contract research organization (CRO) with global execution capabilities. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 pre-clinical and clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia, the US and globally. Novotech has over 2500 staff working across our offices in 13 geographies. For more information visit https://novotech-cro.com/contactMedia ContactDavid JamesE: communications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Data Shows 50% of New Trials Have Sites in Asia Pacific ACN Newswire

Data Shows 50% of New Trials Have Sites in Asia Pacific

December 15, 2022
SYDNEY, AU, Dec 15, 2022 - (ACN Newswire via SEAPRWire.com) - Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of new trials had sites in Asia Pacific.According to the new publication titled "State of the Global Biotech Landscape: Where the Opportunities Lie", demand for Asia Pacific trial sites is strong with almost half of the more than 27,000 clinical trials initiated in 2021 having sites in Asia Pacific. The data shows almost 12,900 of the new trials had sites in Asia Pacific.Download the report here https://novotech-cro.com/whitepapers/state-global-biotech-landscape-where-opportunities-lieThe report also noted that the Asia Pacific region, which has more than 6,772 trial sites each with access to an average of 2,136 million people, has considerable underutilized capacity presenting an opportunity for growth in multinational trials in the region. In addition, analysis of trial growth trends found that Asia Pacific has also seen high phase-level growth over the 5-year analysis period to 2022.- Phases I and II were dominated by Asia Pacific, which served as a trial location in 57% and 49% of trials, respectively.- US and EU remained stable at approximately 20% at phases I through III.- RoW representation is low in phases I and II but on par with the US and EU in phase III.Novotech this month was awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices in the Asia-Pacific contract research organization industry. Novotech has been a recipient of the Frost & Sullivan Asia Pacific Best Practices awards since 2006. Frost & Sullivan identifies companies that consistently develop growth strategies based on a visionary understanding of the future, and effectively address new challenges and opportunities. Frost & Sullivan said: "Our approach involves the deployment of best practices and strategic analytics across a value chain. Against this backdrop, Frost & Sullivan recognizes Novotech for its valuable achievement. Novotech addresses the global drug development market's unmet needs with a strong leadership focus that incorporates client-centric strategies with best-practice implementation. From feasibility assessments to regulatory submission support, data management, medical monitoring, and project management, the company provides a 360-degree approach to drug development for its biotech clients."In response to the Company of the Year Award announcement, Novotech CEO Dr. John Moller said this award is a credit to our entire global team which has decades of biotech drug development experience. "Our global clients benefit from access to our expert teams in Asia Pacific, which is the fastest-growing clinical trial region, due to its vast patient populations and sophisticated medical research infrastructure. Our consistent investment in advanced training and technology systems combine to deliver a specialist full-service biotech CRO solution."Novotech also recently produced a new publication for biotechs considering China for their clinical research, and the relevant processes required for global regulatory approvals. The report details regulatory requirements for biotechs including NDA and IND processes as well as ex-US research guidance for a successful US FDA approval pathway. Novotech provides the relevant regulatory knowledge and drug development pathways specifically designed to support the US FDA approval process, avoiding delays and additional costs.Download whitepaper here https://novotech-cro.com/whitepapers/china-biotech-landscape-opportunities-china-and-path-usfda-approvalNovotech has also recently been benchmarked as a top 10 CRO among the world's leading CROs, is a finalist in the prestigious Scrip awards, and has just been awarded the Gene & Cell Therapy Excellence Award. In Asia Pacific Novotech has more than 50 Leading Site Partnership agreements with major medical research institutions delivering exclusive benefits for sponsors.About Novotech - https://novotech-cro.comNovotech is internationally recognized as the leading Asia Pacific centred contract research organization (CRO) with global execution capabilities. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 pre-clinical and clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia, the US and globally. Novotech has over 2500 staff working across our offices in 13 geographies. For more information visit https://novotech-cro.com/contactMedia ContactDavid Jamescommunications@novotech-cro.comAU: +61 2 8218 2144 USA: +1 415 951 3228Asia: +65 3159 3427 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Fujitsu Limited, Kawasaki Heavy Industries, Ltd., SAP Japan Co., Ltd., Skillnote Corporation JCN Newswire

Fujitsu Limited, Kawasaki Heavy Industries, Ltd., SAP Japan Co., Ltd., Skillnote Corporation

November 22, 2022
TOKYO, Nov 22, 2022 - (JCN Newswire via SEAPRWire.com) - Fujitsu, Kawasaki Heavy Industries Ltd., SAP Japan Co., Ltd., and Skillnote Corporation plan to collaborate on the development of platform services supporting digital transformation (DX) in the manufacturing industry, with a focus on the manufacturing of aircraft, railways, ships, and large machinery. The four companies will combine their experience and know-how in DX, system construction and engineering to create manufacturing platform services that strengthen the supply chain.DX in manufacturing for a more resilient supply chain.Finding ways to respond flexibly to rapid changes in the global economy, including a dramatic reduction in the working age population in many developed countries, represents an ongoing challenge for the manufacturing industry. To this end, the demand for measures to ensure business continuity throughout the supply chain and to standardize and systemize technologies and skills is gaining increasing importance.Many on-site production management tasks still rely on manual labor, however, and especially small and medium-sized manufacturers often face barriers to DX adoption, including trouble securing skilled workers and difficulty in calculating the return on investment. There also remain concerns that the local digitization and systematization of individual companies may create organizational silos that hinder overall optimization of the entire supply chain and operations linked to the engineering chain(1).To address these challenges and to provide a basis for efficient, continuous high-quality manufacturing by using common data and information, Fujitsu, Kawasaki Heavy Industries, SAP Japan and Skillnote plan to develop manufacturing platform services "co-created" with users. Moving forward, the four companies aim to provide subscription-type platform services for user lead system implementation, unified business and unified data that combines high-quality manufacturing management processes already in operation with the community infrastructure among users.1. Features of the platform services(1) Provision of a one-stop business process from the design department to the manufacturing siteIn order to drive the development of the manufacturing industry in the global market, linking the "value" created in the engineering chain to the frontline manufacturing sites in the supply chain, real-time monitoring at the manufacturing sites and feed-back of information to the design department in a fast manner represent important challenges. To achieve this, businesses need to realize tight data coordination between the design department and the manufacturing shop floor, accurate change control as well as visualization of activities.Under the name "Smart-K Project"(2), Kawasaki Heavy Industries, Ltd. Aerospace Systems Company, one of Japan's leading aircraft manufacturers, has standardized the manufacturing process of aircrafts that requires high quality and transparency, and has realized digitization of its business by introducing SAP's "SAP S/4HANA Manufacturing for Production Engineering and Operations (PEO)"(3) provided by Fujitsu and SAP Japan. Within the Smart-K Project, the PEO solution links the manufacturing site with the ERP and PLM systems and the engineering and supply chains in a one-stop manner, enabling real-time understanding of the strict flow down of technology requirements and the current state of the manufacturing site.The four parties aim to leverage the high-quality and efficient business processes cultivated through the Smart-K Project to offer users new platform services that provide value to a wide range of manufacturing supply chains.(2) Helping users to implement systems and improve their DX SkillsThe new platform services aim to provide Fujitsu's system application know-how and contents as a service to enable users to take the lead in the implementation of new systems. It shall further help customers to improve their DX skills to proactively change their operations and continuously improve system operations.(3) Participatory platform servicesIn the area of system implementation, current approaches including "Fit to standard"(4) increasingly aim to reduce the burden on users. While this is an effective method to promote DX and to align business with standard functions, concerns remain that users' requests for system improvements might not be reflected. The new platform services aim to create a new standard by enabling users to share their improvement requests and development priorities.Business operations after the implementation of new systems, especially the role of engineering in the manufacturing industry represent another highly important factor. To this end, the services aim to enhance the value of the platform by providing engineering services such as master creation support necessary for businesses. To maximize the value of the new platform services, the four companies will work on leveraging data on the platform and linking it with various SaaSs. Skillnote provides a SaaS-type service that supports human resource development through skills management, qualification management and training planning at manufacturing sites. With Skillnote's support, the companies will contribute to the further development of the platform services and enable users to link skills management with manufacturing execution of the manufacturing site via the new platform services.2. Roles and responsibilities (including plans)Fujitsu - Construction and operation of platform servicesKawasaki Heavy Industries - Provision of business processesSAP Japan - Provision of applications and platformsSkillnote - Provision of skills management, qualification management and training management solutions for manufacturing sites3. Overview and schedule of the collaborationMoving forward, the four companies plan to build platform services and develop a variety of support services based on hearings with user companies and various organizations. Starting with AeroEdge Co.,Ltd.(5), a manufacturer of components for aircraft engines, the four companies will conduct trials with several companies through the first half of fiscal 2023, with the aim to launch the new services in July 2023.(1) Engineering chain:Work centered on the design department in the manufacturing process.(2) Smart-K:Aircraft manufacturing innovation initiative promoted by Kawasaki Heavy Industries. Fujitsu and SAP Japan introduced SAP's solutions to help streamline aircraft manufacturing business processes.(3) PEO:"Production Engineering & Operation." A method of integrating information on engineering departments and production site management in a one-stop manner to quickly respond to changes in the customer market and quality management at production sites to strengthen competitiveness.(4) Fit to Standard:A method of adapting business operations to ERP standard functions without additional add-on development when implementing ERP systems.(5) AeroEdge Co.,Ltd.:Head office: Ashikaga City, Tochigi Prefecture, Japan; President & CEO: Jun Morinishi.About FujitsuFujitsu's purpose is to make the world more sustainable by building trust in society through innovation. As the digital transformation partner of choice for customers in over 100 countries, our 124,000 employees work to resolve some of the greatest challenges facing humanity. Our range of services and solutions draw on five key technologies: Computing, Networks, AI, Data & Security, and Converging Technologies, which we bring together to deliver sustainability transformation. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$32 billion) for the fiscal year ended March 31, 2022 and remains the top digital services company in Japan by market share. Find out more: www.fujitsu.com.About Kawasaki Heavy IndustriesKawasaki Heavy Industries, Ltd. (Kawasaki) is a technology company that is internationally recognized for developing and offering leading technologies and comprehensive solutions for the design and construction of transportation equipment, industrial plants and energy machinery, and manufactures and sells leisure products such as motorcycles. In recent years, the company has also focused on PCR testing services and carbon neutrality with an eye toward the With Corona era, and has addressed a wide range of social issues. https://global.kawasaki.com/en/About SAP JapanSAP Japan was established in 1992 as the Japanese subsidiary of SAP SE. SAP's strategy is to help every business run as an intelligent, sustainable enterprise. As a market leader in enterprise application software, we help companies of all sizes and in all industries run at their best: SAP customers generate 87% of total global commerce. Our machine learning, Internet of Things (IoT), and advanced analytics technologies help turn customers' businesses into intelligent enterprises. SAP helps give people and organizations deep business insight and fosters collaboration that helps them stay ahead of their competition. We simplify technology for companies so they can consume our software the way they want - without disruption. Our end-to-end suite of applications and services enables business and public customers across 25 industries globally to operate profitably, adapt continuously, and make a difference. With a global network of customers, partners, employees, and thought leaders, SAP helps the world run better and improve people's lives. For more information, visit www.sap.com. SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see www.sap.com/copyright for additional trademark information and notices.About SkillnoteSkillnote Corporation (head office: Chuo-ku, Tokyo; CEO: Takafumi Yamakawa) was founded in 2016 and is a global company providing the Skillnote skill and training management system focused on manufacturing sites. With the vision of "Realize a world where all workers can grow and have a fulfilling career" the company is aiming for the realization of a society where everyone involved in manufacturing works energetically by scientifically analyzing the growth of people working in manufacturing. See www.skillnote-global.com/ for details. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More